FMP

FMP

Enter

GNPX - Genprex, Inc.

Financial Summary of Genprex, Inc.(GNPX), Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients w

About

ceo

Mr. John Rodney Varner

sector

Healthcare

industry

Biotechnology

website

https://www.genprex.com

exchange

NASDAQ

Description

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

CIK

0001595248

ISIN

US3724462037

CUSIP

372446104

Address

3300 Bee Cave Road

Phone

877 774 4679

Country

US

Employee

31

IPO Date

Mar 29, 2018

Summary

CIK

0001595248

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

372446104

ISIN

US3724462037

Country

US

Price

2.71

Beta

-0.57

Volume Avg.

81.41k

Market Cap

4.03M

Shares

-

52-Week

2.51-46.0

DCF

0.44

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.11

P/B

-

Website

https://www.genprex.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest GNPX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep